Giraudo, A.; Sabatier, R.; Rousseau, F.; De Nonneville, A.; Gonçalves, A.; Cecile, M.; Braticevic, C.; Viret, F.; Seguin, L.; Kfoury, M.;
et al. The Use of Cyclin-Dependent Kinase 4/6 Inhibitors in Elderly Breast Cancer Patients: What Do We Know? Cancers 2024, 16, 1838.
https://doi.org/10.3390/cancers16101838
AMA Style
Giraudo A, Sabatier R, Rousseau F, De Nonneville A, Gonçalves A, Cecile M, Braticevic C, Viret F, Seguin L, Kfoury M,
et al. The Use of Cyclin-Dependent Kinase 4/6 Inhibitors in Elderly Breast Cancer Patients: What Do We Know? Cancers. 2024; 16(10):1838.
https://doi.org/10.3390/cancers16101838
Chicago/Turabian Style
Giraudo, Alexandre, Renaud Sabatier, Frederique Rousseau, Alexandre De Nonneville, Anthony Gonçalves, Maud Cecile, Cecile Braticevic, Frederic Viret, Lorene Seguin, Maria Kfoury,
and et al. 2024. "The Use of Cyclin-Dependent Kinase 4/6 Inhibitors in Elderly Breast Cancer Patients: What Do We Know?" Cancers 16, no. 10: 1838.
https://doi.org/10.3390/cancers16101838
APA Style
Giraudo, A., Sabatier, R., Rousseau, F., De Nonneville, A., Gonçalves, A., Cecile, M., Braticevic, C., Viret, F., Seguin, L., Kfoury, M., Naudet, D., Hamon, M., & Tassy, L.
(2024). The Use of Cyclin-Dependent Kinase 4/6 Inhibitors in Elderly Breast Cancer Patients: What Do We Know? Cancers, 16(10), 1838.
https://doi.org/10.3390/cancers16101838
